Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 14/20 | 0.46 |
| ▸ | GRM1 | Q13255 | 13/20 | 0.46 |
| ▸ | GRM7 | Q14831 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7729097 | 0.73 | CYP3A4 (0.56) | GRM4GRM1CYP2C9 | |
| SCHEMBL6789421 | 0.71 | FYN (0.39) | GRM4GRM1GRM7CYP2C9HDAC3 | |
| SCHEMBL6678591 | 0.66 | MAPT (0.50) | GRM4GRM1GRM7 | |
| SCHEMBL6683298 | 0.66 | CYP3A4 (0.60) | GRM4GRM1CYP2C9 | |
| SCHEMBL28943005 | 0.64 | HDAC1 (0.60) | GRM1HDAC3 | |
| SCHEMBL28440762 | 0.63 | AHR (0.55) | GRM4GRM1GRM7 | |
| SCHEMBL7731694 | 0.63 | ESR1 (0.46) | GRM4GRM1 | |
| SCHEMBL4586421 | 0.62 | MAPT (0.56) | — | |
| SCHEMBL6815546 | 0.62 | KMT2A (0.58) | GRM4 | |
| SCHEMBL10726128 | 0.61 | CASP3 (0.66) | CYP1A2HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6716847-B2 | ANTIALLERGENS, ANTIINFLAMMATORY | ASTRAZENECA AB (SE) | 2004-04-06 | — | — | US | disclosed |
| US-6593333-B1 | Processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines. Tumour Necrosis Factor (hereinafter TNF), for example TNF alpha , and various | ASTRAZENECA AB (SE) | 2003-07-15 | — | — | US | disclosed |
| EP-1117653-B1 | QUINOLINE AND QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF CYTOKINE MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2003-02-05 | — | — | EP | disclosed |
| EP-1117653-A1 | CHEMICAL COMPOUNDS | AstraZeneca AB (SE) | 2001-07-25 | — | — | EP | disclosed |
| WO-2000020402-A1 | CHEMICAL COMPOUNDS | ASTRAZENECA AB (SE) | 2000-04-13 | — | — | WO | disclosed |